Shih-Chi Yeh

Title: Innovations in Cancer Treatment by Shih-Chi Yeh

Introduction

Shih-Chi Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, Yeh's work focuses on the development of pharmaceutical compositions that target cancer cells.

Latest Patents

Yeh's latest patents include compositions and methods for the treatment and detection of cancers. One notable patent discloses a pharmaceutical composition comprising antibodies or antigen-binding fragments that bind to globo H, SSEA3, and SSEA-4. These antibodies are designed for use in cancer therapies and diagnostics, targeting various carcinomas, including those found in the brain, skin, lungs, and breast. Another patent similarly focuses on antibodies that bind to SSEA-4, emphasizing their potential in cancer therapies and diagnostics.

Career Highlights

Shih-Chi Yeh is affiliated with Academia Sinica, a leading research institution in Taiwan. His work has garnered attention for its potential impact on cancer treatment and detection. Yeh's innovative approaches aim to improve therapeutic outcomes for patients suffering from various types of cancer.

Collaborations

Yeh collaborates with notable colleagues, including Chi-Huey Wong and Tsui-Ling Hsu, who contribute to his research endeavors. Their combined expertise enhances the development of effective cancer therapies.

Conclusion

Shih-Chi Yeh's contributions to cancer research through his innovative patents highlight the importance of targeted therapies in improving patient outcomes. His work continues to pave the way for advancements in cancer treatment and diagnostics.